| Literature DB >> 25449781 |
Hiroko Nagao-Kitamoto1, Takao Setoguchi2, Sho Kitamoto3, Shunsuke Nakamura1, Arisa Tsuru1, Masahito Nagata1, Satoshi Nagano1, Yasuhiro Ishidou4, Masahiro Yokouchi1, Shinichi Kitajima5, Takako Yoshioka6, Shingo Maeda4, Suguru Yonezawa3, Setsuro Komiya1.
Abstract
It has been reported that GLI2 promotes proliferation, migration, and invasion of mesenchymal stem cell and osteosarcoma cells. To examine the molecular mechanisms of GLI2-mediated osteosarcoma metastasis, we performed a microarray analysis. The gene encoding ribosomal protein S3 (RPS3) was identified as a target of GLI2. Real-time PCR revealed that RPS3 was upregulated in osteosarcoma cell lines compared with normal osteoblast cells. Knockdown of GLI2 decreased RPS3 expression, whereas forced expression of a constitutively active form of GLI2 upregulated the expression of RPS3. RPS3 knockdown by siRNA decreased the migration and invasion of osteosarcoma cells. Although forced expression of constitutively active GLI2 increased the migration of human mesenchymal stem cells, knockdown of RPS3 reduced the up-regulated migration. In contrast, forced expression of RPS3 increased migration and invasion of osteosarcoma cells. Moreover, reduction of migration by GLI2 knockdown was rescued by forced expression of RPS3. Immunohistochemical analysis showed that RPS3 expression was increased in primary osteosarcoma lesions with lung metastases compared with those without. These findings indicate that GLI2-RPS3 signaling may be a marker of invasive osteosarcoma and a therapeutic target for patients with osteosarcoma.Entities:
Keywords: GLI2; Hedgehog; Osteosarcoma; Ribosomal protein S3 (RPS3)
Mesh:
Substances:
Year: 2014 PMID: 25449781 DOI: 10.1016/j.canlet.2014.10.042
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679